Wyeth - Wikipedia
WEBWyeth Pharmaceuticals, formerly Wyeth-Ayerst Laboratories, is the original company founded by the Wyeth brothers, originally known as John Wyeth and Brother. They focused on the research, development, and marketing of prescription drugs.
Pfizer to Acquire Wyeth, Creating the World's Premier …
WEBJan 25, 2009 · Pfizer agreed to acquire Wyeth, a research-based global pharmaceutical company, for $68 billion, creating the world's premier biopharmaceutical company. (Photo: Business Wire)
Pfizer And Wyeth Become One: Working Together For A …
WEBOct 15, 2009 · Pfizer and Wyeth companies become one - Pfizer scientists at Grange Castle, Clondalkin, Ireland, one of the world's leading biopharmaceutical campuses. The combined operation is a more diversified health care company with expanded leadership in human, animal and consumer health. (Photo: Business Wire)
Wyeth -- Company History
WEBApr 9, 2017 · Wyeth is a global pharmaceutical research and manufacturing company. It develops and markets traditional pharmaceuticals, vaccines, and biotechnology products that serve both human and animal health care.
Pfizer Completes Acquisition Of Wyeth
WEB(BUSINESS WIRE)--Pfizer (NYSE: PFE) and Wyeth (NYSE: WYE) announced today that Pfizer has completed its acquisition of Wyeth following the receipt of regulatory approval from all government authorities required by the merger agreement and approval by Wyeth shareholders. Under the terms of the transaction, each outstanding share of …
Pfizer to Acquire Wyeth, Creating the World's Premier …
WEBJan 26, 2009 · Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company. Diversification, Flexibility and Scale Position New Company for Success in Dynamic Global Health Care Environment
Drugmaker Pfizer closes $68B acquisition of Wyeth
WEBOct 15, 2009 · Pfizer Inc. and Wyeth have tied the knot in the drug industry’s most expensive marriage this year. Nine months after Pfizer announced an agreement to buy Wyeth for $68 billion, the deal closed...
Pfizer Agrees to Pay $68 Billion for Rival Drug Maker Wyeth
WEBJan. 25, 2009. The board of Pfizer, the world’s largest drug maker, agreed to acquire a rival, Wyeth, for $68 billion, the companies announced Monday. The deal, if completed, would not only ...
In Wyeth, Pfizer Saw a Promise of Biological Drugs - The New York Times
WEBJan 27, 2009 · Pfizer’s acquisition of Wyeth is a validation of Mr. Poussot’s decision to refocus Wyeth on biologics and on vaccines, drugs that are also derived from biological material.
Pfizer to buy Wyeth in $68-billion deal | Nature
WEBJan 27, 2009 · Pfizer will pay about $68 billion for Wyeth, based in Madison, New Jersey, an unusually large deal given the current financial crisis.
- Some results have been removed